This week the NASDAQ composite gave back (-0.4%) its gain from the previous week (+0.3%). For biotechs generally the picture was brighter: +1.3% for the NASDAQ biotech composite, and +5.7% for S&P biotech composite. The S&P biotech index is inching closer to being in the black YTD.
For the individual contest selected stocks, the best performer for the week is GMDA (+62% of its starting price), following the FDA approval of a cell treatment for cord blood derived stem cells to fight blood based cancer, on Monday. By the end of the week they had announced a public offering of additional shares and warrants producing a $22 million cash infusion This priced improvement brought them back roughly to where they had been at the start of the year. Second place performer for the week, INZY (+57%), on the other hand, was building on more or less continuous growth since mid-March strengthening their position in first place for YTD performance (+490%). In the weekly loser list second place OMER (-30%) had no particular reason other than profit-taking. And JSPR racked up another week in the red, fifth worst for the week (-17%), changing places with EYEN in the YTD standings dropping to fourth.
The contest portfolios also had a good week, generally, with only three portfolios in the red, and adding +$3.6k to the average portfolio (+$3.7k to the median), but less than the S&P biotech index. YTD the median portfolio’s gains (+$16.5k) have now passed the NASDAQ composite (+$15.3k). The best portfolio for the week was ERIKOTTO (+$10.4k), who clearly benefitted from their 5% choice of INZY, yielding (+$2.9k). This was out shown by his 10% investment in OCUL, the third place stock of the week, adding +$4.2k. This moved him up two spots in the YTD rankings to 7th place.
The ordering of the YTD rankings from 3rd through 6th place was unchanged from last week. Last week’s second place YTD portfolio , ALONER, had a bad week. A 10% bet on CRIS was the predominant reason for this loss of -$1.4k for the week. But BLADERUNNER, who has occupied the YTD top spot since the first week of the contest, had put down 15% on CRIS, which with his 20% position in JSPR, had a worse week, -$5.7k. This results in ALONER now taking over first place YTD, with a profit of $42k. The contest has tightened appreciably with the top four portfolios having a spread of less than $4.6k.
Report Time Ranges
|
|
|
|
|
|
From
|
To
|
|
|
|
|
|
|
|
|
Recent
|
4/14/23
|
4/21/2023
|
|
|
|
|
|
|
|
|
YTD
|
12/31/2022
|
|
|
|
|
Index Portfolios’ Performance
|
|
|
|
|
Symbol
|
Recent P/L
|
Recent %
|
YTD P/L
|
|
|
|
|
|
|
|
|
^IXIC
|
-$487.37
|
-0.4%
|
$15,343.98
|
|
|
|
|
|
|
|
|
^NBI
|
$1,337.78
|
1.3%
|
$1,456.28
|
|
|
|
|
|
|
|
|
^SPSIBI
|
$5,347.15
|
5.7%
|
-$1,533.17
|
|
|
|
|
Share Performance
|
Recent Performance
|
YTD Performance
|
|
Top Five
|
|
Bottom Five
|
|
Top Five
|
|
Bottom 5
|
Symbol
|
P/L / Initial Price
|
Symbol
|
P/L / Initial Price
|
Symbol
|
YTD P/L / Initial Price
|
Symbol
|
YTD P/L/ Initial Price
|
GMDA
|
61.5%
|
PSNL
|
-30.8%
|
INZY
|
486.7%
|
ALT
|
-64.8%
|
INZY
|
57.1%
|
OMER
|
-30.5%
|
EYEN
|
200.6%
|
FULC
|
-62.5%
|
OCUL
|
41.6%
|
CRIS
|
-26.5%
|
JSPR
|
183.6%
|
BCAB
|
-57.9%
|
VKTX
|
26.2%
|
NAUT
|
-17.2%
|
OMER
|
150.4%
|
BLCM
|
-53.1%
|
FDMT
|
25.4%
|
JSPR
|
-16.6%
|
PRVB
|
130.1%
|
GLYC
|
-52.5%
|
Average and Median Portfolio Performance
|
|
Recent P/L
|
|
|
|
YTD P/L
|
|
|
|
Avg.
|
Median
|
|
|
|
Avg
|
Median
|
|
|
|
$3,592.09
|
$3,746.64
|
BULBAMAN
|
|
$13,970.60
|
$16,489.68
|
TECHNETIUM
|
Top Seven Portfolio Performances
|
Top Recent Performers
|
Top YTD Performers
|
Contestant (Prev. Rank)
|
Recent P/L
|
P/L vs. ^SPSIBI
|
YTD P/L (Rank)
|
Contestant (Prev. Rank)
|
YTD P/L
|
vs. Top Portfolio
|
P/L vs. ^SPSIBI
|
Rec. P/L (Rank)
|
1 - ERIKOTTO (11)
|
$10,416.29
|
$5,069.14
|
$16,823.63 (7)
|
1 - ALONER (2)
|
$41,884.14
|
——
|
$43,417.31
|
-$1,363.38 (13)
|
2 - JACK HARTMANN (10)
|
$10,035.93
|
$4,688.78
|
$7,695.43 (10)
|
2 - BLADERUNNER (1)
|
$40,334.86
|
$1,549.28
|
$41,868.04
|
-$5,722.69 (15)
|
3 - TOMATO (13)
|
$9,332.18
|
$3,985.03
|
$37,328.11 (4)
|
3 - ARTHUR RADLEY (3)
|
$39,593.58
|
$2,290.56
|
$41,126.75
|
$4,249.96 (7)
|
4 - RAJU_BIJLEE (7)
|
$8,061.13
|
$2,713.98
|
-$14,782.92 (14)
|
4 - TOMATO (4)
|
$37,328.11
|
$4,556.03
|
$38,861.28
|
$9,332.18 (3)
|
5 - TECHNETIUM (14)
|
$7,989.76
|
$2,642.61
|
$16,489.68 (8)
|
5 - RKRW (5)
|
$32,224.11
|
$9,660.03
|
$33,757.29
|
$5,063.19 (6)
|
6 - RKRW (9)
|
$5,063.19
|
-$283.96
|
$32,224.11 (5)
|
6 - STEVE LOKNESS (6)
|
$18,937.56
|
$22,946.59
|
$20,470.73
|
-$4,956.13 (14)
|
7 - ARTHUR RADLEY (1)
|
$4,249.96
|
-$1,097.19
|
$39,593.58 (3)
|
7 - ERIKOTTO (9)
|
$16,823.63
|
$25,060.51
|
$18,356.81
|
$10,416.29 (1)
|
Top Portfolios’ Contents
|
Top Recent Performance Portfolio (ERIKOTTO)
|
Top YTD Performance Portfolio (ALONER)
|
Symbol (Rank)
|
Current Allocation
|
Value/Total | ROI
|
YTD Stock P/L
|
Recent Stock P/L
|
% Current Price Change for $1,000 P/L
|
Symbol (Rank)
|
Initial Allocation
|
Value/Total | ROI
|
YTD Stock P/L
|
Recent Stock P/L
|
% Current Price Change for $1,000 P/L
|
CABA
|
15.0%
|
11.9% | -7.1%
|
-$1,070.27
|
$1,264.86
|
7.2%
|
AFMD
|
10%
|
4.8% | -31.5%
|
-$3,148.39
|
$737.10
|
14.6%
|
DAWN
|
10.0%
|
5.4% | -36.3%
|
-$3,633.83
|
$631.97
|
15.7%
|
CDTX
|
10%
|
10.5% | 49.4%
|
$4,941.16
|
$661.11
|
6.7%
|
FULC
|
10.0%
|
3.2% | -62.5%
|
-$6,250.00
|
$439.56
|
26.7%
|
CLSD
|
10%
|
6.7% | -5.4%
|
-$535.71
|
-$357.14
|
10.6%
|
ICVX
|
5.0%
|
3.3% | -23.7%
|
-$1,187.03
|
$563.60
|
26.2%
|
CRDF
|
10%
|
7.5% | 5.7%
|
$571.43
|
-$71.43
|
9.5%
|
INZY
|
5.0%
|
25.1% | 486.7%
|
$24,333.33
|
$2,857.14
|
3.4%
|
CRIS
|
10%
|
10.2% | 45.3%
|
$4,529.09
|
-$2,652.73
|
6.9%
|
LIFE
|
10.0%
|
7.3% | -14.4%
|
-$1,438.36
|
-$159.82
|
11.7%
|
CRVS
|
10%
|
8.8% | 24.7%
|
$2,470.59
|
$235.29
|
8.0%
|
OCUL
|
10.0%
|
19.6% | 128.8%
|
$12,882.56
|
$4,163.70
|
4.4%
|
KZIA
|
10%
|
16.0% | 127.7%
|
$12,767.93
|
$1,301.02
|
4.4%
|
PDSB
|
10.0%
|
4.3% | -50.1%
|
-$5,007.58
|
-$227.27
|
20.0%
|
MGTA
|
10%
|
13.7% | 94.4%
|
$9,437.97
|
-$283.54
|
5.1%
|
PRQR
|
10.0%
|
5.3% | -37.8%
|
-$3,783.78
|
$189.19
|
16.1%
|
MRNA
|
10%
|
5.5% | -21.6%
|
-$2,158.45
|
-$904.69
|
12.8%
|
URGN
|
15.0%
|
14.5% | 13.2%
|
$1,978.58
|
$693.35
|
5.9%
|
PRVB
|
10%
|
16.2% | 130.1%
|
$13,008.51
|
-$28.38
|
4.3%
|
|
